Initiation of Breast Cancer by Endogenous Estrogens: Mechanism and Prevention.
Abstract
We have carried out experiments in cell culture systems demonstrating the unique ability of 16a-OHE1 to bring about hyperproliferation with increased anchorage-independent growth. This, as well as other studies, has indicated the carcinogen like activity of 16a-OHE1. We have also carried out studies with mouse and human explant cultures of two types (high and low risk for breast cancer) and a marked increase in 16a-hydroxylation was observed with cultures from the high risk mice or women. The differences demonstrated in these normal tissues indicate the importance of a chronic increase in estrogen 16a-hydroxylation prior to the development of breast tumors. Experiments with 16a-OHE1 in the control of PS2 gene expression in MCF-7 cells demonstrate that an 'irreversible' interaction between estrogen receptors and 16a-OHE1 can cause sustained response in estrogen-responsive genes. Also, experiments to identity the cytochrome P450 gene which catalyzes estrogen 16a-hydroxylation have indicated that it is probably Cyp2-dx. Further studies should confirm whether or not it is this gene which is responsible for the enzyme. Once identified it may be possible to alter the expression of this gene in breast cells and therefore reduce the risk of breast cancer.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 30, 1995
- Accession Number
- ADA300368
Entities
People
- Jack Fishman
Organizations
- Weill Cornell Medicine